-
Tavapadon (developmental code
names CVL-751, PF-06649751) is a
dopamine receptor agonist for the
treatment of Parkinson's disease.,
under development...
-
Cerevel drugs and
treatments at
varying stages of
development include:
Tavapadon (Parkinson's)
Emraclidine (Schizophrenia, Alzheimer's)
Darigabat (Epilepsy)...
- 2022, CVL-871 is in
phase 2
clinical trials for dementia-related apathy.
Tavapadon (CVL-751) "CVL 871 - AdisInsight".
Hatzipantelis CJ,
Langiu M, Vandekolk...
- 6669571
Propylnorapomorphine Rotigotine SKF-89,145 SKF-89,626
Stepholidine Tavapadon Tetrahydropalmatine PAMs Tetrahydroisoquinolines: DETQ DPTQ Mevidalen...
- 6669571
Propylnorapomorphine Rotigotine SKF-89,145 SKF-89,626
Stepholidine Tavapadon Tetrahydropalmatine PAMs Tetrahydroisoquinolines: DETQ DPTQ Mevidalen...
- 6669571
Propylnorapomorphine Rotigotine SKF-89,145 SKF-89,626
Stepholidine Tavapadon Tetrahydropalmatine PAMs Tetrahydroisoquinolines: DETQ DPTQ Mevidalen...
- 6669571
Propylnorapomorphine Rotigotine SKF-89,145 SKF-89,626
Stepholidine Tavapadon Tetrahydropalmatine PAMs Tetrahydroisoquinolines: DETQ DPTQ Mevidalen...
- 6669571
Propylnorapomorphine Rotigotine SKF-89,145 SKF-89,626
Stepholidine Tavapadon Tetrahydropalmatine PAMs Tetrahydroisoquinolines: DETQ DPTQ Mevidalen...
- 6669571
Propylnorapomorphine Rotigotine SKF-89,145 SKF-89,626
Stepholidine Tavapadon Tetrahydropalmatine PAMs Tetrahydroisoquinolines: DETQ DPTQ Mevidalen...
- 6669571
Propylnorapomorphine Rotigotine SKF-89,145 SKF-89,626
Stepholidine Tavapadon Tetrahydropalmatine PAMs Tetrahydroisoquinolines: DETQ DPTQ Mevidalen...